Increased mortality in a Danish cohort of young people with Type 1 diabetes mellitus followed for 24 years

Diabetic Medicine

Volumn 34, Issue 3, 2017, Pages 380-386

  Sandahl, K ^a   Nielsen, L B ^a   Svensson, J ^a   Johannesen, J ^a   Pociot, F ^a   Mortensen, H B ^a   Hougaard, P ^b   Broe, R ^b,c   Rasmussen, M L ^b,c   Grauslund, J ^b,c   Peto, T ^b,d   Olsen, B S ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^d MOORFIELDS EYE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; BIOLOGICAL MARKER; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADOLESCENT; ADULT; ARTICLE; CAUSE OF DEATH; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DANISH CITIZEN; DEATH; DEATH CERTIFICATE; DENMARK; FEMALE; FOLLOW UP; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MORTALITY RATE; MULTICENTER STUDY; POPULATION; REGISTRATION; RISK FACTOR; STANDARDIZED MORTALITY RATIO; SURVIVAL ANALYSIS; BLOOD; CLINICAL TRIAL; COHORT ANALYSIS; COMPLICATION; DIABETIC COMPLICATION; DISEASE EXACERBATION; EPIDEMIOLOGY; MORTALITY; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; REGISTER; YOUNG ADULT;

ADOLESCENT; ADULT; BIOMARKERS; CHILD; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DENMARK; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLYCATED HEMOGLOBIN A; HUMANS; MALE; MORTALITY; PROSPECTIVE STUDIES; REGISTRIES; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84963976719     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.13124     Document Type: Article

References (30)

1. Patterson CC, Dahlquist G, Harjutsalo V, Joner G, Feltbower RG, Svensson J et al. Early mortality in EURODIAB population-based cohorts of type 1 diabetes diagnosed in childhood since 1989. Diabetologia 2007; 50: 2439–2442.
2. Secrest AM, Becker DJ, Kelsey SF, Laporte RE, Orchard TJ. Cause-specific mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes. Diabetes 2010; 59: 3216–3222.
3. Writing Group for the DCCT/EDIC Reasearch Group, Orchard TJ, Nathan DM, Zinman B, Cleary P, Brillon D et al. Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality. JAMA 2015; 313: 45–53.
4. Borch-Johnsen K. Improving prognosis of type 1 diabetes. Mortality, accidents, and impact on insurance. Diabetes Care 1999; 22(Suppl 2): B1–3.
5. Jørgensen ME, Almdal TP, Carstensen B. Time trends in mortality rates in type 1 diabetes from 2002 to 2011. Diabetologia 2013; 56: 2401–2404.
6. Miller RG, Secrest AM, Sharma RK, Songer TJ, Orchard TJ. Improvements in the life expectancy of type 1 diabetes: the Pittsburgh Epidemiology of Diabetes Complications study cohort. Diabetes 2012; 61: 2987–2992.
7. Skrivarhaug T, Bangstad H-J, Stene LC, Sandvik L, Hanssen KF, Joner G. Long-term mortality in a nationwide cohort of childhood-onset type 1 diabetic patients in Norway. Diabetologia 2006; 49: 298–305.
8. Mortensen HB, Hartling SG, Petersen KE. A nation-wide cross-sectional study of glycosylated haemoglobin in Danish children with Type 1 diabetes. Diabet Med 1988; 5: 871–876.
9. Mortensen HB, Marinelli K, Nørgaard K, Main K, Kastrup KW, Ibsen KK et al. A nation-wide cross-sectional study of urinary albumin excretion rate, arterial blood pressure and blood glucose control in Danish children with Type 1 diabetes mellitus. Danish Study Group of Diabetes in Childhood. Diabet Med 1990; 7: 887–897.
10. Mortensen HB, Villumsen J, Vølund A, Petersen KE, Nerup J. Relationship between insulin injection regimen and metabolic control in young Danish Type 1 diabetic patients. The Danish Study Group of Diabetes in Childhood. Diabet Med 1992; 9: 834–839.
11. Mortensen HB, Hougaard P, Ibsen KK, Parving HH. Relationship between blood pressure and urinary albumin excretion rate in young Danish Type 1 diabetic patients: comparison to non-diabetic children. Danish Study Group of Diabetes in Childhood. Diabet Med 1994; 11: 155–161.
12. Olsen BS, Johannesen J, Sjølie AK, Borch-Johnsen K, Hougarrdss P, Thorsteinsson B et al. Metabolic control and prevalence of microvascular complications in young Danish patients with Type 1 diabetes mellitus. Danish Study Group of Diabetes in Childhood. Diabet Med 1999; 16: 79–85.
13. Broe R, Rasmussen ML, Frydkjaer-Olsen U, Olsen BS, Mortensen HB, Peto T et al. The 16–year incidence, progression and regression of diabetic retinopathy in a young population-based Danish cohort with type 1 diabetes mellitus: The Danish Cohort of Pediatric Diabetes, 1987 (DCPD1987). Acta Diabetol 1987; 2014: 413–420.
14. Olsen BS, Sjølie AK, Hougaard P, Johannesen J, Marinelli K, Jacobsen BB et al. The significance of the prepubertal diabetes duration for the development of retinopathy and nephropathy in patients with type 1 diabetes. J Diabetes Complicat 2004; 18: 160–164.
15. Grauslund J, Green A, Sjølie AK. Proliferative retinopathy and proteinuria predict mortality rate in type 1 diabetic patients from Fyn County, Denmark. Diabetologia 2008; 51: 583–588.
16. Grauslund J. Long-term mortality and retinopathy in type 1 diabetes. Acta Ophthalmol (Copenh) 2010; 88: 1–14.
17. Borch-Johnsen K, Kreiner S, Deckert T. Mortality of type 1 (insulin-dependent) diabetes mellitus in Denmark: a study of relative mortality in 2930 Danish type 1 diabetic patients diagnosed from 1933 to 1972. Diabetologia 1986; 29: 767–772.
18. Washington RE, Orchard TJ, Arena VC, LaPorte RE, Secrest AM, Tull ES. All-cause mortality in a population-based type 1 diabetes cohort in the U.S. Virgin Islands. Diabetes Res Clin Pract 2014; 103: 504–509.
19. Dawson SI, Willis J, Florkowski CM, Scott RS. All-cause mortality in insulin-treated diabetic patients: a 20-year follow-up. Diabetes Res Clin Pract 2008; 80: e6–9.
20. Allemann S, Saner C, Zwahlen M, Christ ER, Diem P, Stettler C. Long-term cardiovascular and non-cardiovascular mortality in women and men with type 1 and type 2 diabetes mellitus: a 30-year follow-up in Switzerland. Swiss Med Wkly 2009; 139: 576–583.
21. Grauslund J, Jørgensen TM, Nybo M, Green A, Rasmussen LM, Sjølie AK. Risk factors for mortality and ischemic heart disease in patients with long-term type 1 diabetes. J Diabetes Complicat 2010; 24: 223–228.
22. Lind M, Svensson AM, Kosiborod M, Gudbjörnsdottir S, Pivodic A, Wedel H et al. Glycemic control and excess mortality in type 1 diabetes. N Engl J Med 2014; 371: 1972–1982.
23. Cooper MN, de Klerk NH, Jones TW, Davis EA. Clinical and demographic risk factors associated with mortality during early adulthood in a population-based cohort of childhood-onset Type 1 diabetes. Diabet Med 2014; 31: 1550–1558.
24. Schoenaker DA, Simon D, Chaturvedi N, Fuller JH, Soedamah-Muthu SS, EURODIAB Prospective Complications Study Group. Glycemic control and all-cause mortality risk in type 1 diabetes patients: the EURODIAB prospective complications study. J Clin Endocr Metab 2014; 99: 800–807.
25. Fredheim S, Johansen A, Thorsen SU, Kremke B, Nielsen LB, Olsen BS et al. Nationwide reduction in the frequency of severe hypoglycemia by half. Acta Diabetol 2015; 52: 591–599.
26. Danish Diabetes Annual Report, 2014. Available at https://www.sundhed.dk/sundhedsfaglig/kvalitet/kliniske-kvalitetsdatabaser/kroniske-sygdomme/diabetes/ Last accessed 8 July 2015.
27. Johansen A, Kanijo B, Fredheim S et al. Prevalence and predictors of severe hypoglycemia in Danish children and adolescents with diabetes. Pediatr Diabetes 2015; 16: 354–360.
28. Miller KM, Foster NC, Beck RW, Bergenstal RM, DuBose SN, DiMeglio LA et al. Current State of Type 1 Diabetes Treatment in the U.S.: Updated Data From the T1D Exchange Clinic Registry. Diabetes Care 2015; 38: 971–978.
29. Steineck I, Cederholm J, Eliasson B, Rawshani A, Eeg-Olofsson K, Svensson AM et al. Insulin pump therapy, multiple daily injections, and cardiovascular mortality in 18 168 people with type 1 diabetes: observational study. BMJ 2015; 350: h3234–h3234.
30. Swift PG, Skinner TC, deBeaufort CE, Cameron FJ, Aman J, Aanstoot HJ et al. Target setting in intensive insulin management is associated with metabolic control: the Hvidoere childhood diabetes study group centre differences study 2005. Pediatr Diabetes 2010; 11: 271–278.